Conversations with Kellogg Leaders:
Joseph C. Papa '83 MBA
Chief Executive Officer, Bausch + Lomb

Join Dean Cornelli as she hosts Joseph C. Papa ’83 MBA, chief executive officer of Bausch + Lomb. Papa will discuss his approaches for effectively leading a business through a turnaround, as well as strategies he’s implemented to find common ground with diverse board members.

Please register in advance. The Zoom link will be provided upon registration.

To see additional upcoming programs, please visit our Kellogg Alumni Virtual Programs page. There, you can also view recordings of prior webinars.

REGISTER HERE

JOSEPH C. PAPA

Chief Executive Officer, Bausch + Lomb

Joseph C. Papa has more than 35 years of experience in the pharmaceutical, health care and specialty pharmaceutical industries.

Before joining Bausch + Lomb, Mr. Papa was the chairman of the board and chief executive officer of Bausch Health Companies Inc. ("Bausch Health") from 2016 to 2022. Previously, he was the chief executive officer of the Perrigo Company from 2006 to 2016. He also served as chairman and chief executive officer of Cardinal Health's Pharmaceutical Technologies and Services business unit from 2004 to 2006. Prior to that, he was president and chief operating officer for Watson Pharmaceuticals from 2001 to 2004, president of Global Country Operations for Pharmacia's North American business from 2000 to 2001 and president of Searle's U.S. Operations from 1997 to 2000. Before that, he served in various general management, sales, marketing and R&D positions during his 15-year career at Novartis Pharmaceuticals Corporation from 1983 to 1997. He led teams that successfully launched several blockbuster pharmaceutical products, including Lotrel, Diovan and Celebrex, and he is the patent holder for a cardiovascular combination treatment containing Amlodipine and Benazepril.

In 2014, Harvard Business Review ranked Mr. Papa 47th on its "2014 Best Performing CEOs in the World" list. He was also recognized on Israel-based Calcalist Magazine's "Best Chief Executive Officer for the Year" list for 2013 and 2014. Additionally, he was named one of the World's Best CEOs by Barron's magazine in 2012, which noted Perrigo "generated one of the best shareholder returns in the S&P 500 in the past five years."

He is a past member of the UConn Foundation Board of Directors and the Smith & Nephew Board of Directors, where he served as chairman of the Remuneration Committee. He currently serves as lead independent director and chairman of the Compensation Committee for Prometheus Biosciences. He is also a member of the Board of Candel Therapeutics.

Mr. Papa holds a Bachelor of Science in Pharmacy from the University of Connecticut and an MBA from Kellogg Graduate School of Management at Northwestern University. In 2012, he received an Honorary Doctor of Science degree from the University of Connecticut's School of Pharmacy.